Clinical trials: Ketamine Causing Adverse Effects in Therapeutic Use
Ketamine Causing Adverse Effects in Therapeutic Use
Comparing Three Different Doses of Intrathecal Ketamine
The aim of this study is to compare the postoperative analgesic effect of three different doses of intrathecal ketamine as an adjuvant to bupivacaine in patients undergoing knee arthroscopy.
- Trial name
- NCT05074823
- Testing
- Ketamine 0.1 mg, Ketamine 0.2 mg, Ketamine 0.3 mg
- Where
- Egypt
- Volunteers
- 105 people
- Sponsor
- Assiut University
Intensive Care Unit Syndrome, Mechanical Ventilation Complication
Ketamine Infusion as Sedative Analgesic in Severe ARDS
To evaluate whether ketamine is a safe sedative-analgesic agent to be used in an intensive care unit (ICU) setting as compared to traditionally used agents such as propofol, opioids, and midazolam
- Conditions
- Intensive Care Unit Syndrome, Mechanical Ventilation Complication, Sedatives and Hypnotics Causing Adverse Effects in Therapeutic Use, Delirium
- Trial name
- KISS (NCT04818827)
- Where
- United States
- Volunteers
- 124 people
- Sponsor
- Interfaith Medical Center